University of Pittsburgh logo

Jeremy G. Stone, MD

  • Clinical Assistant Professor
  • Director Cerebrovascular Surgery, UPMC Hamot

Jeremy G. Stone, MD, is a board eligible neurosurgeon with CAST-accredited subspecialty fellowship training in neuroendovascular surgery, completing both residency and fellowship at the University of Pittsburgh. He currently practices with Great Lakes Neurosurgery and Neurointervention at UPMC Hamot in Erie, Pennsylvania serving as clinical assistant professor and director of cerebrovascular surgery.

Dr. Stone enjoys general neurosurgery with clinical focus on open cerebrovascular, neuroendovascular, minimally invasive techniques, and spine deformity. He also leads scientific discovery with participation as site principal investigator in several clinical trials.

Specialized Areas of Interest

Cerebrovascular (open and endovascular neurosurgery); degenerative spine disease and spinal deformity with emphasis on minimally invasive 360-degree approaches for deformity correction; stroke.

Board Certifications

American Board of Neurological Surgery (board eligible)

Hospital Privileges

UPMC Hamot
UPMC Mercy
UPMC Presbyterian

Professional Organization Membership

Alpha Omega Alpha
American Association of Neurological Surgery
AANS/CNS Cerebrovascular Section
Congress of Neurological Surgeons
North American Spine Society
Society of Neurointerventional Surgeons

Professional Activities

UPMC Neurosurgery and Neurology Value Analysis Committee

Education & Training

  • BS, Biology/Psychology, Case Western Reserve University, 2009
  • MD, University of Hawaii, 2014
  • CAST-Accredited Fellowship, Neuroendovascular Surgery, University of Pittsburgh, 2020
  • Residency, Neurological Surgery, University of Pittsburgh, 2021

Honors & Awards

  • Best Off-Service Teacher Award, Orthopedic Surgery Residency, UPMC Hamot, 2021
  • UPMC Medical Education LEAP Award for Patient Safety and Quality Improvement, 2017, 2020
  • Oral Presentation Award, Second Annual Graduate Medical Education Quality and Safety Symposium, University of Pittsburgh, 2019
  • Best Resident Research Presentation Runner Up, Stuart Rowe Society Lectureship, University of Pittsburgh, 2019
  • Top Score, American Board of Neurological Surgery Written Board Exam, 2018
  • Frank and Mary McDowell Award for Excellence in Surgery, 2014
  • Windsor and Mary Cutting Excellence in the Basic Sciences Award, 2014
  • Bernard Yim Award for Top Performance in Internal Medicine Clerkship, American College of Physicians, University of Hawaii John A. Burns School of Medicine, 2013
  • Po'okela and Noi'i Award for Outstanding Research, 2014
  • American College of Physicians Bernard Him Award for Top Performance in Internal Medicine, 2013

Research Activities

• Multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA (OCEANIC-STROKE).

Phase 3 program of the Oral faCtor Eleven A iNhibitor asundexLan as novel anti-thrombotiC STROKE study.

• Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA). 

Two-stage Phase III trial randomizing subjects with stroke attributed to 70-99% intracranial atherosclerotic stenosis to 1. ticagrelor + aspirin, 2. low dose rivaroxaban + aspirin, 3. clopidogrel + aspirin. 

• Protection against Emboli during caRotid artery stenting using a 3-in-1 delivery system comprised oF a pOst-dilation balloon, integRated eMbolic filter, and A Novel Carotid stEnt II (PERFORMANCE II). 

Prospective, single-arm, multicenter clinical trial to evaluate the safety and effectiveness of the Neuroguard IEP System for the treatment of carotid artery stenosis.